RETA -4%/AH on purportedly positive phase-2 data in Friedreich’s ataxia: https://globenewswire.com/news-release/2017/06/01/1005786/0/en/Reata-Pharmaceuticals-Inc-Announces-Positive-Data-From-Part-One-of-Moxie-Trial-of-Omaveloxolone-for-Friedreich-s-Ataxia.html